Interactions of the human papillomavirus E7 protein with cell cycle regulators

Seminars in Cancer Biology

Volumn 7, Issue 6, 1996, Pages 327-337

  Jones, D Leanne ^a   Münger, Karl ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell division cycle; Human papillomavirus; Keratinocyte differentiation; Protein degradation; Tumor suppressor protein; Viral oncoprotein

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; DNA; ONCOPROTEIN; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

APOPTOSIS; CELL CYCLE; GROWTH REGULATION; HUMAN; NONHUMAN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS REPLICATION; WART VIRUS;

EID: 0030418318     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0042     Document Type: Review

References (66)

1. 1. zur Hausen H (1996) Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288:F55-F78
2. 2. Organization, IAfRoCWH, Human Papillomaviruses (1995) IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 64. International Agency for Research on Cancer/World Health Organization, Lyon, France 409
3. 3. Münger K, Scheffner M, Huibregtse JM, Howley PM (1992) Interactions of HPV E6 and E7 with tumour suppressor gene products. Cancer Surv 12:197-217
4. 4. Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79
5. 5. Dyson N, Howley PM, Münger K, Harlow E (1989) The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937
6. 6. Münger K, Phelps WC (1993) The human papillomavirus-E7 protein as a transforming and transactivating factor. Biochem Biophys Acta 1155:111-123
7. 7. Halpern A, Münger K (1995) HPV16 E7: primary structure and biological properties, in Human Papillomavirus (Myers G, et al, Ed.) Los Alamos National Laboratory, Los Alamos, NM, p. III/ 58-III/ 73
8. 8. Dollard SC, Wilson JL, Demeter LM, Bonnez W, Reichman RC, Broker TR, Chow LT (1992) Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev 6:1131-1142
9. 9. Meyers C, Frattini MG, Hudson JB, Laimins LA (1992) Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973
10. 10. McCance DJ, Kopan R, Fuchs E, Laimins LA (1988) Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 85:7169-7173
11. 11. Woodworth CD, Cheng S, Simpson S, Hamacher L, Chow LT, Broker TR, DiPaolo JA (1992) Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene 7:619-626
12. 12. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT (1995) Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev 9:2335-2349
13. 13. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330
14. 14. Nevins JR (1992) E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429
15. 15. Edmonds C, Vousden KH (1989) A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol 63:2650-2656
16. 16. Banks L, Edmonds C, Vousden K (1990) Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH 3T3 cells. Oncogene 5:1383-1389
17. 17. Phelps WC, Münger K, Yee CL, Barnes JA, Howley PM (1992) Structure-function analysis of the human papillomavirus E7 oncoprotein. J Virol 66:2418-2427
18. 18. Brokaw JL, Yee CL, Münger K (1994) A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. Virology 205:603-607
19. 19. McIntyre MC, Frattini MG, Grossman SR, Laimins LA (1993) Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J Virol 67:3142-3150
20. 20. Clemens KE, Brent R, Gyuris J, Münger K (1995) Dimerization of the human papillomavirus E7 oncoprotein in vivo. Virology 214:289-293
21. 21. Zwerschke W, Joswig S, Jansen Durr P (1996) Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene 12:213-220
22. 22. Jewers RJ, Hildebrandt P, Ludlow JW, Kell B, McCance DJ (1992) Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J Virol 66:1329-1335
23. 23. Wu EW, Clemens KE, Heck DV, Münger K (1993) The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol 67:2402-2407
24. 24. Huang PS, Patrick DR, Edwards G, Goodhart PJ, Huber HE, Miles L, Garsky VM, Oliff A, Heimbrook DC (1993) Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol 13:953-960
25. 25. Dyson N, Guida P, Münger K, Harlow E (1992) Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 66:6893-6902
26. 26. Tommasino M, Adamczewski JP, Carlotti F, Barth CF, Manetti R, Contorni M, Cavalieri F, Hunt T, Crawford L (1993) HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 8:195-202
27. 27. Arroyo M, Bagchi S, Raychaudhuri P (1993) Association of the human papillomavirus type 16 E7 protein with the S-phase specific E2F-cyclin A complex. Mol Cell Biol 13:6537-6546
28. 28. Davies R, Hicks R, Crook T, Morris J, Vousden K (1993) Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 67:2521-2528
29. 29. McIntyre MC, Ruesch MN, Laimins LA ( 1996) Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p 107. Virology 215:73-82
30. 30. Mal A, Poon RYC, Howe PH, Toyoshima H, Hunter T, Harter ML (1996) Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380:262-265
31. 31. Zerfass-Thorne K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Durr P (1996) Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330
32. 32. Paulovich AG, Toczyski DP, Hartwell LH (1997) When checkpoints fail. Cell 88:315-321
33. 33. White AE, Livanos EM, Tlsty TD (1994) Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8:666-667
34. 34. Levine AJ (1997) p53, cellular gatekeeper for growth and division. Cell 88:323-331
35. 35. Eldeiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
36. 36. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
37. 37. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
38. 38. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266:1821-1828
39. 39. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90:3988-3992
40. 40. Slebos RJC, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, Cho KR (1994) p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91:5320-5324
41. 41. Vousden KH, Vojtesek B, Fisher C, Lane D (1993) HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53. Oncogene 8:1697-1702
42. 42. Demers GW, Foster SA, Halbert CL, Galloway DA (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA 91:4382-4386
43. 43. Hickman ES, Picksley SM, Vousden KH (1994) Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene 9:2177-2181
44. 44. Jones DL, Münger K (1997) Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol 71:2905-2912
45. 45. Demers GW, Espling E, Harry JB, Etscheid BG, Galloway DA (1996) Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J Virol 70:6862-6869
46. 46. Scheffner M, Nuber U, Huibregtse JM (1995) Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373:81-83
47. 47. Stubdal H, Zalvide J, Decaprio JA (1996) Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J Virol 70:2781-2788
48. 48. Boyer SN, Wazer DE, Band V (1996) E7 protein of human papillomavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620-4624
49. 49. Scheffner M, Münger K, Huibregtse JM, Howley PM (1992) Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. EMBO J 11:2425-2431
50. 50. Barbosa MS, Edmonds C, Fisher C, Schiller JT, Lowy DR, Vousden KH (1990) The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II. EMBO J 9:153-160
51. 51. Hateboer G, Kerkhoven RM, Shvarts A, Bernards R, Beijersbergen RL (1996) Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev 10:2960-2970
52. 52. Hofmann F, Martelli F, Livingston DM, Wang Z (1996) The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev 10:2949-2959
53. 53. Demers GW, Halbert CL, Galloway DA (1994) Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198:169-174
54. 54. Lowe SW, Ruley HE (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7:535-545
55. 55. Pan HC, Griep AE (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes Dev 8:1285-1299
56. 56. Howes KA, Ransom LN, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ (1994) Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8:1300-1310
57. 57. Pan HC, Griep AE (1995) Temporally distinct patterns of p53-dependent and and p53-independent apoptosis during mouse lens development. Genes Dev 9:2157-2169
58. 58. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP (1995) Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92:5451-5455
59. 59. Missero C, Di Cunto F, Kiyokawa H, Koff A, Dotto GP (1996) The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 10:3065-3075
60. 60. Davies RC, Vousden KH (1992) Functional analysis of human papillomavirus type 16 E7 by complementation with advenovirus E1A mutants. J Gen Virol 73:2135-2139
61. 61. Jochmus-Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L (1989) Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 81:1698-1704
62. 62. Eckner R (1996) p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol Chem 377:685-688
63. 63. Chen PL, Riley DJ, Chen Y, Lee WH (1996) Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 10:2794-2804
64. 64. Novitch BG, Mulligan GJ, Jacks T, Lassar AB (1996) Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J Cell Biol 135:441456
65. 65. Janicke RU, Walker PA, Lin XY, Porter AG (1996) Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. Embo J 15:6969-6978
66. 66. An B, Dou QP (1996) Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res 56:438-442